missouri

Home/Tag: missouri

2019 Juvenile Arthritis Symposium

St. Louis University School of Medicine

Arthritis Foundation – Missouri

Saturday, March 2, 2019

Program Information

An estimated 300,000 children in the U.S. — that’s 1 in 250 kids — are affected by some form of JA. This disease takes a unique physical and emotional toll on kids, often resulting in debilitating pain and feelings of loneliness or depression. JA can make it especially challenging for kids to say Yes — Yes to playing, Yes to hanging out with friends, Yes to spending time with family, Yes to being a kid!

Presented by

Baptist Logo

Please join the Arthritis Foundation for the 2019 JA Symposium. Dr. Jordan Jones of Children’s Mercy Hospital will speak to families about the latest advancements in pediatric rheumatology. Arthritis Foundation staff will share what we do to try and help you and your family in navigating life with juvenile arthritis. At the end of our program each family will be provided free tickets to the exhibit at Union Station as well as tickets to visit Science City!

There is no cost to attend this event. You must pre-register all members of your family that will be in attendance. Enter the number of people attending the event below and click next. On the second page you will be asked to enter information for all those attending. Once submitted you will receive an email confirming your reservation.

By submitting this form you agree to the JA Day Waiver.

Space is limited. Pre-registration for this free event is mandatory.

If you have any questions please contact Brooke Hilst at bhilst@arthritis.org or 913-259-7153.

Opioids and the Workplace CME

Mizzou // University of Missouri

Mizzou // University of Missouri

January 10 – 11, 2019

There is a compelling need to change how we look at the opioid problem, specifically its impact on workers and the workforce.

This two-day event will kick off a series of programs around Missouri designed to bring together people who make policy, people who influence policy, and those affected by these policies.

The goal is to develop a realistic action plan, developed by and for the people most involved with the problem.

We invite you to be a part of the discussion, and to help initiate real change in Missouri.

Target Audience:

  • Business leaders who are in position to influence how their business’ employment practices are set.
  • Labor leaders who recruit, train and maintain a large force of ready-trained workers, particularly from organizations that also provide health insurance plans.
  • Health Care professionals interested in looking for alternative treatments and ways to reduce OUD.
  • Community members, those who work directly in the field with OUD sufferers as well as family members of sufferers and others who want to know more about what can be done differently than is being done now.

Objectives/Outcomes

  • Understand how opioids are impacting the workforce
  • Understand how and why the current employment practices dealing with opioids are problematic and likely to get worse
  • Explore new ideas and ways of dealing with pain management, medication, perspectives of Opioid Use Disorder (OUD) recovery, as well as return to work policies.
  • Develop changes that could be made concerning employment and the intersection of consequences of the opioid crisis.
  • Learn current information on the opioid crisis
  • Discuss the crisis as well as solutions with individuals from different backgrounds

Topics Include:

  • Defining the opioid use crisis and its impact on the workforce
  • The economic impact of addiction on individuals, businesses and the community
  • Examining what does and doesn’t work in dealing with the crisis
  • Building collaborations
  • Creating realistic strategies

Activity approved for AMA PRA Category 1 Credit(s)™

The University of Missouri Sinclair School of Nursing is an approved provider of continuing education by the Midwest Multistate Division, an accredited approver by the American Nurses’ Credentialing Center’s Commission on Accreditation.

Midwest Multistate Division Provider Number MO 1019-7

The Missouri Bar has approved this program for 11.4 hours of CLE credit.

Pharmacy: The Continuing Education Committee of the Board of Pharmacy has reviewed and approved the conference for 1 CE(s) per session. Program number: 2018-11-11

Presented by: Labor Studies Program, UMSL | University of Missouri ExtensionMU Sinclair School of Nursing | MU Center for Continuing Medical Education & Physician Lifelong Learning

Conference information will be added as it becomes available.

16th Annual Galaxy of Gastroenterology

Washington University School of Medicine

Washington University School of Medicine

November 2 & 3, 2018

Who Should Attend?

This seminar is designed for primary care physicians, gastroenterologists, gastrointestinal surgeons and their associates who participate in the care of patients with gastrointestinal and hepatic disorders.

The course will also be of value to technicians, nurses and physicians who participate in endoscopy, gastrointestinal motility procedures, and pH-monitoring procedures.

Parts of this activity may also be of benefit to pulmonologists and ear, nose, throat specialists.

Course Director

Gregory S. Sayuk, MD, MPH

Learning & Performance Objectives

The intended result of this continuing medical education activity is to improve knowledge, competence, performance and patient outcomes in the management of gastroenterological diseases by primary care physicians, gastroenterologists, and ancillary staff involvement in the management of gastroenterological diseases.  At the completion of this seminar the participant should be able to:

  • Review clinical presentation and work-up of common GI ailments, including anorectal disorders, IBS, and celiac disease.
  • Explain diagnostic and therapeutic algorithms relevant to GI disorders.
  • Comprehend the mechanistic basis for management of commonly encountered GI ailments.
  • Become aware of the newest techniques, procedures and therapies in gastroenterology, including endo-FLIP.
  • Discuss the evaluation and monitoring of management of inflammatory bowel diseases (IBD).
  • Discuss new paradigms in the medical management of liver disease, including hepatitis C.
  • Discuss the management options available for obscure GI bleeding.
  • Analyze new investigative and therapeutic options in the management of gastroparesis and gastroesophageal reflux.
  • Recognize the use of pharmacologic management in functional GI disorders.
  • Review current approaches to diagnosis and management of alcoholic and non-alcoholic fatty liver.
  • Recognize the options for colon cancer screening and the clinical factors associated with hereditary GI cancer syndromes.

Accreditation

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:

American Medical Association (AMA): Washington University School of Medicine in St. Louis designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC): Washington University School of Medicine in St. Louis designates this live activity for a maximum of 11 ANCC contact hours.

Accreditation Council for Pharmacy Education (ACPE) This activity is approved for contact hours 11.5 (1.15 CEUs). Attending the full program will earn contact hours 11.5(1.15 CEUs). JA0000340-0000-19-004-L01-P Unique Universal Activity Number. To be awarded credit, participants must have participated in all sessions for the day credit is claimed and complete activity evaluation

ABIM MOC Points: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.5 MOC points in Medical Knowledge in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

SLRA Presentation & Dinner – September 2018

St. Louis University School of Medicine

St. Louis Rheumatology Association

Thursday, September 20th, 2018

Drug Pricing; How did we get here and where are we going?

Presenter: Steve Miller, MD, MBA, Senior Vice President & Chief Medical Officer, Express Scripts

Steve Miller, MD, MBASteve Miller has served as Chief Medical Officer at Express Scripts since 2006, focusing on supporting government relations, leading the Pharmacy & Therapeutics committee, managing the Medical Affairs team and interfacing with client groups.

He received his medical degree from the University of Missouri-Kansas City, and he trained in the Pathology and Research fellowship at the University of Alabama at Birmingham.

He degrees in Internal Medicine which he recieved at the University of Colorado, Nephrology at Washington University, and did a cardiology research fellowship at University of California-San Francisco. Miller earned his MBA at Olin.

Dr. Steve Miller’s expertise represents years as a  medical researcher, clinician and administrator, and spans numerous healthcare  subjects. Since joining the company in 2005, Dr. Miller has represented Express Scripts as a presenter at nationwide conferences.

At Express Scripts, he is actively involved in developing their clinical programs and advancing the use of generic pharmaceuticals and  specialty medications. Dr. Miller is a leader in the promotion of legislation to create a pathway at the U.S. Food and Drug Administration for the regulation of biogenerics and biosimilars.

Prior to joining Express Scripts, Dr. Miller was the vice president and chief  medical officer at Barnes-Jewish Hospital, Washington University School of  Medicine in St. Louis.

6:15 – 7:00 pm Registration

7:00 – 9:00 pm Presentation and dinner

Herbie’s

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.  All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.

Rural hospital closures spike this summer

Over the last two months, the number of rural hospital closures has risen rapidly to 87 total closures (since 2010). In rural America, health care is a pillar of the community. It helps to create and foster a sustainable and livable environment for rural Americans, and without health care, without a hospital, a rural community will crumble.

Here in our home state, Twin Rivers Regional Medical Center, a 116 bed PPS Hospital in Kennett, Missouri closed on June 12, the fourth rural hospital in Missouri to close. Just before its closures ad decision was made for Twin Rivers Regional Medical Center to consolidate operations with Poplar Bluff (Mo.) Regional Medical Center.

“As healthcare delivery evolves and medical innovation makes inpatient services less needed, consolidating operations with the larger resources of Poplar Bluff Regional Medical Center became the most sustainable plan for the future,” Twin Rivers Regional Medical Center CEO Christian Jones said in a statement to KAIT. “We plan to continue offering excellent outpatient care locally, which is how 95 percent of our patients’ medical needs were provided last year.”

Twin Rivers Regional Medical Center’s 259 employees will be laid off when the hospital closes, according to a Worker Adjustment and Retraining Notification Act notice filed April 30. However, those employees had the opportunity to meet with representatives of Poplar Bluff Regional Medical Center last week to help them identify positions they may be able to transfer to, according to the report.

As access to care in rural communities disappears, we need the support of Congress now more than ever to stop the flood of hospital closures and create an environment in which innovation can thrive. A multifaceted approach is necessary to address the struggles of rural health care providers including hospitals:

  • The first prong of this approach is to ensure rural providers reimbursement rates are sufficient to allow them to keep their doors open.
  • second prong is to support measures that reduce the cost of providing care including through regulatory relief efforts that reduce costs without negatively impacting patient care.
  • The third prong of this approach is to support new models that allow communities to retain necessary access to local care including a local emergency room while right sizing their facilities to flexibly meet the needs of the specific community.

Together, these policies can all begin to bring rural health care into the 21stCentury and ensure its successful future.

SLRA Presentation & Dinner – March 2018

Saint Louis University School of Medicine

St. Louis Rheumatology Association

Wednesday, March 21, 2018

Jeffrey A. Sparks, MD, MMSc

CME: Update on the Studies to Evaluate the Etiology and Public Health Burden of Rheumatic Diseases

Jeffrey A. Sparks, MD, MMSc -Division of Rheumatology/Immunology & Assistant Professor of Medicine at Harvard Medical School.

Dr. Sparks is a rheumatologist and population scientist with an overall focus on using patient-oriented and epidemiologic research studies to evaluate the etiology, outcomes, and public health burden of rheumatic diseases such as rheumatoid arthritis (RA). In particular, he performs studies to evaluate the genetic, environmental, serologic, and familial risk factors for RA, clinical trials for RA prevention, RA outcomes research focusing on the respiratory burden of RA, evaluates metabolic factors such as weight loss for RA outcomes, and investigates rheumatic manifestations of osseous sarcoidosis.

6:30 – 7:30 pm Registration

7:30 – 9:00 pm Presentation and dinner

Nieman Marcus, Zodiac Room, Hwy 40 and

Lindbergh

REGISTER FOR CME

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.

 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.

SLRA Presentation & Dinner – February 2018

Saint Louis University School of Medicine

St. Louis Rheumatology Association

Wednesday, February 21, 2018

Richard Brasington, M.D., F.A.C.P.

Update on Clinical Research and Treatment of Inflammatory Arthritis

Richard Brasington, M.D., F.A.C.P.
Professor of Medicine
Division of Immunology/Rheumatology
Washington University School of Medicine

6:30– 7:30 pm Registration

7:30 – 9:00 pm Presentation and dinner

The New Herbie’s
8100 Maryland Avenue in Clayton
314-769- 9595

REGISTER FOR CME

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.

 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.

SLRA Presentation & Dinner – November 2017

Saint Louis University School of Medicine

St. Louis Rheumatology Association

Wednesday, November 15th, 2017

Dr. Sterling West

ACR Meeting – Review of Clinical Presentations: Lupus and RA

Dr. Sterling West is Professor of Medicine at the University of Colorado School of Medicine and Co-Director of the Metabolic Bone Disease Clinic.

Following 30+ years as the prior Fellowship Director, Dr. West’s major focus continues to be on patient care and teaching. His present interest is in the maintenance and assessment of clinical competency in Rheumatology.

He is an invited speaker on multiple rheumatology topics at national and regional conferences and has over 100 original research and educational publications. He is editor of the book, Rheumatology Secrets. He is a Master in both the American College of Physicians (MACP) and the American College of Rheumatology (MACR).

6:00 – 6:30 pm Registration

6:30 – 9:00 pm Presentation and dinner

Nieman Marcus, Zodiac Room, Hwy 40 and

Lindbergh

REGISTER FOR CME

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.

 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.

“Pursue Excellence” – The PSN 2017 Annual Conference

PSN - Premier Specialty Network

Premier Specialty Network 10th Annual Conference

August 11th & 12th 2017

This 2-day event will give attendees the opportunity to learn about the latest research and best practices in the field, and participate in a wide range of networking opportunities with renowned experts and colleagues from around the country.

The conference has 5 keynote presentations from several specialists and providers in the field, all focused on new understanding and skill development to support and enhance our missions. In addition, the conference has a marketplace with exhibitors who will showcase new resources, training, and products that support our vision.

Reserve your room now at the beautiful Lodge of the Four Seasons in Lake Ozark. We have procured reduced room rates for PSN. These discounted room rates will only be available for our group through May 26 and you must mention PSN to receive it. After May 26th, rooms will be available at the regular rates.

Conference Agenda

Friday

Times Details
6:00pm-8:30pm Exhibitor Set-up
8:00pm-11:00pm Meet and Greet, Everyone is Welcome, Fire and Ice Plaza

Saturday

Times Details
6:00am-7:00am Exhibitor Set-up
7:00am-7:30am Registration, Exhibits Open, Introductions
7:30am-8:15am Breakfast, Product Theater Sponsored by Novartis
8:15am-9:00am Joan Houska – Healthcare Policy & Advocacy Director
Johnson & Johnson Healthcare Systems
9:00am-9:45am Dr. Alan Erickson – Rheumatologist
9:45am-10:00am Break, Visit Exhibits
10:00am-10:45am Dr. Laurence Kinsella – Neurologist
10:45am-11:30am Dr. Luvell Glanton – Interventional Pain Management
11:45am-12:45pm Dana Gonnerman – CEO, Mastering Excellence
“Diagnosis:  Annoying Patients.  Is There a Cure?  Part 2
Decoding the Communication Language of Your Patients STAT”
12:45am-1:30pm Lunch, Product Theater Sponsored by Abbvie
1:30pm -2:00pm Closing Comments – Dr. Robert Jackson

Exhibits Break Down

SLRA Presentation & Dinner – July 2017

Saint Louis University School of Medicine

St. Louis Rheumatology Association

Thursday, July 20, 2017

Dr. Phil Mease

Potpourri of hot topics from EULAR; abstracts of PsA,SpA, RA, et al

Dr Phil Mease is a Clinical Professor at the University of Washington School of Medicine in Seattle Director of the Rheumatology Clinical Research Division of Swedish Medical Center

His clinical practice is based at Seattle Rheumatology Associates. He conducts clinical trials of emerging therapies for rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, osteoarthritis and lupus. He conducts research in disease state metrics and is the Co-Chair of three working groups of OMERACT (Outcome Measures in Rheumatology Clinical Trials) on psoriatic arthritis, fibromyalgia and single joint assessment, as well as being a member of the Soluble Biomarker working group. He is a founding organizer and President of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), and a member of SPARTAN (Spondyloarthritis Research & Treatment Network).

6:15 – 7:00 pm Registration

7:00 – 9:00 pm Presentation and dinner

Nieman Marcus, Zodiac Room, Hwy 40 and

Lindbergh

REGISTER FOR CME

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.

 All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education, is the sponsor for CME credits.